Published in Histochem Cell Biol on October 05, 2005
Muscle giants: molecular scaffolds in sarcomerogenesis. Physiol Rev (2009) 1.92
Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum. J Cell Sci (2009) 1.40
Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. J Biol Chem (2008) 1.25
Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly. Mol Biol Cell (2009) 1.23
Different obscurin isoforms localize to distinct sites at sarcomeres. FEBS Lett (2007) 1.20
Obscurin-like 1, OBSL1, is a novel cytoskeletal protein related to obscurin. Genomics (2007) 1.19
The rho-guanine nucleotide exchange factor domain of obscurin regulates assembly of titin at the Z-disk through interactions with Ran binding protein 9. Mol Biol Cell (2008) 1.15
Cardiac ankyrins in health and disease. J Mol Cell Cardiol (2009) 1.08
New aspects of obscurin in human striated muscles. Histochem Cell Biol (2008) 1.05
The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle. Mol Biol Cell (2009) 0.99
Ankyrin protein networks in membrane formation and stabilization. J Cell Mol Med (2009) 0.96
Krp1 (Sarcosin) promotes lateral fusion of myofibril assembly intermediates in cultured mouse cardiomyocytes. Exp Cell Res (2008) 0.96
Early incorporation of obscurin into nascent sarcomeres: implication for myofibril assembly during cardiac myogenesis. Histochem Cell Biol (2008) 0.95
Targeted deletion of the zebrafish obscurin A RhoGEF domain affects heart, skeletal muscle and brain development. Dev Biol (2009) 0.93
Localization of ank1.5 in the sarcoplasmic reticulum precedes that of SERCA and RyR: relationship with the organization of obscurin in developing sarcomeres. Histochem Cell Biol (2008) 0.92
Obscurins: Goliaths and Davids take over non-muscle tissues. PLoS One (2014) 0.91
Large isoforms of UNC-89 (obscurin) are required for muscle cell architecture and optimal calcium release in Caenorhabditis elegans. PLoS One (2012) 0.90
Developmental expression and differential cellular localization of obscurin and obscurin-associated kinase in cardiac muscle cells. J Cell Biochem (2008) 0.90
Obscurins: unassuming giants enter the spotlight. IUBMB Life (2013) 0.89
TC10 controls human myofibril organization and is activated by the sarcomeric RhoGEF obscurin. J Cell Sci (2009) 0.87
Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization. BMC Genomics (2010) 0.85
Investigation of Pathogenic Genes in Chinese sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome Sequencing. Sci Rep (2015) 0.82
The sarcomeric M-region: a molecular command center for diverse cellular processes. Biomed Res Int (2015) 0.76
Deregulated Ca(2+) cycling underlies the development of arrhythmia and heart disease due to mutant obscurin. Sci Adv (2017) 0.75
Developing hearts need their SPEG. Circulation (2009) 0.75
The histochemistry and cell biology vade mecum: a review of 2005-2006. Histochem Cell Biol (2006) 0.75
Obscure functions: the location-function relationship of obscurins. Biophys Rev (2017) 0.75
Recent progress in histochemistry. Histochem Cell Biol (2007) 0.75
Rho and Rac take center stage. Cell (2004) 10.64
Perspective: machines for RNAi. Genes Dev (2005) 9.37
Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods (2002) 6.67
siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov (2004) 4.73
Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet (2002) 3.81
The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ Res (2001) 3.68
Genomewide view of gene silencing by small interfering RNAs. Proc Natl Acad Sci U S A (2003) 2.56
OrthoDisease: a database of human disease orthologs. Hum Mutat (2004) 2.52
Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab (2003) 2.42
Titin: properties and family relationships. Nat Rev Mol Cell Biol (2003) 2.18
Muscle assembly: a titanic achievement? Curr Opin Cell Biol (1999) 2.07
Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly. J Cell Biol (2001) 1.97
Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. Cardiovasc Res (1998) 1.90
Obscurin is a ligand for small ankyrin 1 in skeletal muscle. Mol Biol Cell (2003) 1.80
The Caenorhabditis elegans gene unc-89, required fpr muscle M-line assembly, encodes a giant modular protein composed of Ig and signal transduction domains. J Cell Biol (1996) 1.77
Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles. J Cell Biol (2003) 1.72
Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun (2002) 1.70
Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc (2005) 1.65
Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. Exp Cell Res (2004) 1.63
Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy. J Cell Biol (2004) 1.62
Defining and assaying RNAi in mammalian cells. Mol Cell (2005) 1.60
Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro. Nat Med (2000) 1.55
Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro. Mol Med (1999) 1.53
Independent assembly of 1.6 microns long bipolar MHC filaments and I-Z-I bodies. Cell Struct Funct (1997) 1.51
Nebulin: the nebulous, multifunctional giant of striated muscle. Trends Cardiovasc Med (2003) 1.44
Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol (1997) 1.44
Dynamics of Z-band based proteins in developing skeletal muscle cells. Cell Motil Cytoskeleton (2005) 1.43
The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation? J Struct Biol (2004) 1.42
Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene. Hum Genet (2004) 1.41
Gene silencing by adenovirus-delivered siRNA. FEBS Lett (2003) 1.37
Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med (Berl) (1998) 1.37
Myofibrillogenesis in the first cardiomyocytes formed from isolated quail precardiac mesoderm. Dev Biol (2003) 1.36
Three new isoforms of Caenorhabditis elegans UNC-89 containing MLCK-like protein kinase domains. J Mol Biol (2004) 1.27
The sensitive giant: the role of titin-based stretch sensing complexes in the heart. Trends Cell Biol (2004) 1.26
Obscurin regulates the organization of myosin into A bands. Am J Physiol Cell Physiol (2004) 1.22
Myomesin is a molecular spring with adaptable elasticity. J Mol Biol (2005) 1.21
A functional knock-out of titin results in defective myofibril assembly. J Cell Sci (2000) 1.18
Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res (2000) 1.18
Titin domain patterns correlate with the axial disposition of myosin at the end of the thick filament. J Mol Biol (1996) 1.17
Desmin in muscle formation and maintenance: knockouts and consequences. Cell Struct Funct (1997) 1.15
Studies of the interaction between titin and myosin. J Cell Biol (1995) 1.13
M-band: a safeguard for sarcomere stability? J Muscle Res Cell Motil (2003) 1.12
Dynamics of obscurin localization during differentiation and remodeling of cardiac myocytes: obscurin as an integrator of myofibrillar structure. J Histochem Cytochem (2004) 1.09
Dimerisation of myomesin: implications for the structure of the sarcomeric M-band. J Mol Biol (2005) 1.09
Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases. Dev Genes Evol (2004) 1.09
Rapid response of cardiac obscurin gene cluster to aortic stenosis: differential activation of Rho-GEF and MLCK and involvement in hypertrophic growth. Biochem Biophys Res Commun (2003) 1.08
Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol (1997) 1.07
PEVK extension of human soleus muscle titin revealed by immunolabeling with the anti-titin antibody 9D10. J Struct Biol (1998) 1.06
Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. Development (2002) 1.05
RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J Mol Endocrinol (2004) 1.04
Thick filament assembly occurs after the formation of a cytoskeletal scaffold. J Muscle Res Cell Motil (1999) 1.03
New concepts in hypertrophic cardiomyopathies, part I. Circulation (2001) 1.02
New approaches to phenotypic analysis in adult mice. J Mol Cell Cardiol (2001) 1.02
Antisense oligonucleotide experiments elucidate the essential role of titin in sarcomerogenesis in adult rat cardiomyocytes in long-term culture. J Cell Sci (2000) 1.00
Myofibrillogenesis and reversible disassembly of myofibrills as adaptive reactions of cardiac muscle cells. Acta Physiol Scand Suppl (1991) 0.99
Properties of titin immunoglobulin and fibronectin-3 domains. J Biol Chem (2004) 0.97
A targeted deletion of the C-terminal end of titin, including the titin kinase domain, impairs myofibrillogenesis. J Cell Sci (2003) 0.96
RNA interference: historical overview and significance. Methods Mol Biol (2004) 0.95
RNA interference: past, present and future. Curr Issues Mol Biol (2005) 0.94
Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes. J Pharmacol Exp Ther (2004) 0.93
Fishing out proteins that bind to titin. J Cell Biol (2001) 0.92
Desmin-related myopathies in mice and man. Acta Physiol Scand (2001) 0.92
[Monoclonal antibodies to the muscle isoform of alpha-actinin--a marker for the study of the differentiation of skeletal and cardiac muscles]. Tsitologiia (1989) 0.89
Regulation of heparin-binding epidermal growth factor-like growth factor mRNA levels by hypertrophic stimuli in neonatal and adult rat cardiac myocytes. J Biol Chem (1994) 0.88
Soaking up RNAi. Mol Cell (2003) 0.84
Adult rat cardiomyocytes in culture A model system to study the plasticity of the differentiated cardiac phenotype at the molecular and cellular levels. Trends Cardiovasc Med (2011) 0.84
Myocyte hypertrophy: the long and winding RhoA'd. J Clin Invest (1999) 0.83
Sarcomere number regulation maintained after immobilization in desmin-null mouse skeletal muscle. J Exp Biol (2001) 0.82
Weakness of a giant: mutations of the sarcomeric protein titin. Trends Mol Med (2002) 0.82
Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity. Mol Genet Metab (2004) 0.81
Cellular engineering of ventricular adult rat cardiomyocytes. Cardiovasc Res (2003) 0.79
[Changes in alpha-actinin localization and myofibrillogenesis in rat cardiomyocytes under cultivation]. Tsitologiia (1989) 0.79
Gene silencing using adenoviral RNAi vector in vascular smooth muscle cells and cardiomyocytes. Methods Mol Med (2005) 0.78
Myofilament protein phosphorylation by PKC in genetically engineered adult cardiac myocytes. Methods Mol Biol (2003) 0.78
Muscle disease: a giant feels the strain. Nat Med (2005) 0.77
Triiodothyronine restricts myofibrillar growth and enhances beating frequency in cultured adult rat cardiomyocytes. Basic Res Cardiol (1998) 0.77
Effect of alpha adrenergic stimulation and carnitine palmitoyl transferase I inhibition on hypertrophying adult rat cardiomyocytes in culture. Mol Cell Biochem (1995) 0.75
PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med (2004) 4.50
Muscle giants: molecular scaffolds in sarcomerogenesis. Physiol Rev (2009) 1.92
Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ Res (2004) 1.80
Obscurin is a ligand for small ankyrin 1 in skeletal muscle. Mol Biol Cell (2003) 1.80
Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice. Circ Res (2005) 1.80
Muscle intermediate filaments and their links to membranes and membranous organelles. Exp Cell Res (2007) 1.68
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol (2013) 1.65
Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med (2006) 1.53
Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele. Mol Cell Biol (2006) 1.51
Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation (2010) 1.49
In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Proc Natl Acad Sci U S A (2012) 1.39
Obscurin modulates the assembly and organization of sarcomeres and the sarcoplasmic reticulum. FASEB J (2006) 1.39
Excitation-contraction coupling changes during postnatal cardiac development. J Mol Cell Cardiol (2009) 1.36
Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization. J Cell Sci (2007) 1.34
Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase. Am J Physiol Heart Circ Physiol (2007) 1.29
An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J Exp Med (2005) 1.29
Obscurin is required for the lateral alignment of striated myofibrils in zebrafish. Dev Dyn (2006) 1.29
Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo. Neuroreport (2008) 1.29
Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart. J Appl Physiol (1985) (2003) 1.26
Recovery of function in skeletal muscle following 2 different contraction-induced injuries. Arch Phys Med Rehabil (2007) 1.25
Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly. Mol Biol Cell (2009) 1.23
Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes. J Biol Chem (2003) 1.23
Obscurin regulates the organization of myosin into A bands. Am J Physiol Cell Physiol (2004) 1.22
Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane. Proc Natl Acad Sci U S A (2013) 1.21
Different obscurin isoforms localize to distinct sites at sarcomeres. FEBS Lett (2007) 1.20
Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade. Circ Res (2002) 1.20
Obscurin-like 1, OBSL1, is a novel cytoskeletal protein related to obscurin. Genomics (2007) 1.19
The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. Eur Heart J (2008) 1.17
The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival. Mol Biol Cell (2008) 1.17
The rho-guanine nucleotide exchange factor domain of obscurin regulates assembly of titin at the Z-disk through interactions with Ran binding protein 9. Mol Biol Cell (2008) 1.15
Obscurin: a multitasking muscle giant. J Muscle Res Cell Motil (2005) 1.14
Mapping the binding site on small ankyrin 1 for obscurin. J Biol Chem (2007) 1.11
Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circ Cardiovasc Genet (2013) 1.11
Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries. Am J Physiol Cell Physiol (2009) 1.10
Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function. J Mol Biol (2006) 1.10
Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19. Mol Biol Cell (2005) 1.10
Dynamics of obscurin localization during differentiation and remodeling of cardiac myocytes: obscurin as an integrator of myofibrillar structure. J Histochem Cytochem (2004) 1.09
Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases. Dev Genes Evol (2004) 1.09
Quantitative measurement of Ca²(+) in the sarcoplasmic reticulum lumen of mammalian skeletal muscle. Biophys J (2010) 1.09
Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy. Am J Pathol (2009) 1.08
Association of small ankyrin 1 with the sarcoplasmic reticulum. Mol Membr Biol (2005) 1.08
Rapid response of cardiac obscurin gene cluster to aortic stenosis: differential activation of Rho-GEF and MLCK and involvement in hypertrophic growth. Biochem Biophys Res Commun (2003) 1.08
Cardiomyocyte function after burn injury and lipopolysaccharide exposure: single-cell contraction analysis and cytokine secretion profile. Shock (2006) 1.06
Calcitriol modulation of cardiac contractile performance via protein kinase C. J Mol Cell Cardiol (2006) 1.06
De novo myofibrillogenesis in C2C12 cells: evidence for the independent assembly of M bands and Z disks. Am J Physiol Cell Physiol (2005) 1.06
Reduced serum content and increased matrix stiffness promote the cardiac myofibroblast transition in 3D collagen matrices. Cardiovasc Pathol (2011) 1.05
Sarcolemmal organization in skeletal muscle lacking desmin: evidence for cytokeratins associated with the membrane skeleton at costameres. Mol Biol Cell (2002) 1.05
The hydrophilic domain of small ankyrin-1 interacts with the two N-terminal immunoglobulin domains of titin. J Biol Chem (2002) 1.04
Designing heart performance by gene transfer. Physiol Rev (2008) 1.03
Myosin binding protein-C slow: an intricate subfamily of proteins. J Biomed Biotechnol (2010) 1.02
Physiology, structure, and susceptibility to injury of skeletal muscle in mice lacking keratin 19-based and desmin-based intermediate filaments. Am J Physiol Cell Physiol (2011) 1.02
The muscular dystrophies: from genes to therapies. Phys Ther (2005) 1.01
Cloning and characterization of cytokeratins 8 and 19 in adult rat striated muscle. Interaction with the dystrophin glycoprotein complex. J Biol Chem (2004) 1.00
Cooperativity between the phosphorylation of Thr95 and Ser77 of NHERF-1 in the hormonal regulation of renal phosphate transport. J Biol Chem (2010) 0.99
The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle. Mol Biol Cell (2009) 0.99
Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy. Ann Neurol (2006) 0.98
Immunophenotyping and protein profiling of Fontan-associated plastic bronchitis airway casts. Ann Am Thorac Soc (2013) 0.98
Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy. PLoS One (2012) 0.97
C5a-blockade improves burn-induced cardiac dysfunction. J Immunol (2007) 0.97
The anti-apoptotic protein HAX-1 is a regulator of cardiac function. Proc Natl Acad Sci U S A (2009) 0.96
Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy. Exp Neurol (2007) 0.96
Ordered assembly of the adhesive and electrochemical connections within newly formed intercalated disks in primary cultures of adult rat cardiomyocytes. J Biomed Biotechnol (2010) 0.96
Early incorporation of obscurin into nascent sarcomeres: implication for myofibril assembly during cardiac myogenesis. Histochem Cell Biol (2008) 0.95
Myosin binding protein-C: a regulator of actomyosin interaction in striated muscle. J Biomed Biotechnol (2011) 0.95
Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance. FASEB J (2012) 0.94
Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament function. J Mol Med (Berl) (2007) 0.94
Loss of actomyosin regulation in distal arthrogryposis myopathy due to mutant myosin binding protein-C slow. FASEB J (2013) 0.94
Targeted deletion of the zebrafish obscurin A RhoGEF domain affects heart, skeletal muscle and brain development. Dev Biol (2009) 0.93
The actin binding domain of βI-spectrin regulates the morphological and functional dynamics of dendritic spines. PLoS One (2011) 0.93
Mesenteric pseudoaneurysm and cerebral stroke as sequelae of infective endocarditis in an adolescent. J Pediatr Surg (2008) 0.93
The kinase domains of obscurin interact with intercellular adhesion proteins. FASEB J (2013) 0.92
Sarcomere thin filament regulatory isoforms. Evidence of a dominant effect of slow skeletal troponin I on cardiac contraction. J Biol Chem (2003) 0.92
Role of an alternatively spliced form of alphaII-spectrin in localization of connexin 43 in cardiomyocytes and regulation by stress-activated protein kinase. J Mol Cell Cardiol (2007) 0.92
HAX-1: a family of apoptotic regulators in health and disease. J Cell Physiol (2011) 0.92
Myosin binding protein-C slow is a novel substrate for protein kinase A (PKA) and C (PKC) in skeletal muscle. J Proteome Res (2011) 0.91
Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies. Physiol Genomics (2005) 0.90
Myocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium. J Biol Chem (2014) 0.90
Developmental expression and differential cellular localization of obscurin and obscurin-associated kinase in cardiac muscle cells. J Cell Biochem (2008) 0.90
Obscurins: unassuming giants enter the spotlight. IUBMB Life (2013) 0.89
Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction. Am J Physiol Heart Circ Physiol (2004) 0.89
Physiological and histological changes in skeletal muscle following in vivo gene transfer by electroporation. Am J Physiol Cell Physiol (2011) 0.89
Local wound p38 MAPK inhibition attenuates burn-induced cardiac dysfunction. Surgery (2009) 0.86
Electrostatic interactions mediate binding of obscurin to small ankyrin 1: biochemical and molecular modeling studies. J Mol Biol (2011) 0.86
Severe hypertrophic cardiomyopathy in an infant with a novel PRKAG2 gene mutation: potential differences between infantile and adult onset presentation. Pediatr Cardiol (2009) 0.85
Postnatal changes in sarcolemmal organization in the mdx mouse. Neuromuscul Disord (2005) 0.85
Unmasking potential intracellular roles for dysferlin through improved immunolabeling methods. J Histochem Cytochem (2011) 0.85